A Win For ADC Therapeutics SA
Fri, Dec 06, 2024 at 07:28 PM
ADC Therapeutics SA (ADCT:NYSE) rocketted at $3.13, representing a gain of 63%. On Fri, Dec 06, 2024, ADCT:NYSE hit a New 2-Week High of $3.13. The stock got featured on our News Catalysts scanner on Fri, Dec 06, 2024 at 09:11 AM in the 'BIOTECH' category. From Fri, Nov 22, 2024, the stock recorded 55.56% Up Days and 50.00% Green Days
About ADC Therapeutics SA (ADCT:NYSE)
ADC Therapeutics SA is a United States-based clinical-stage oncology-focused biotechnology company.
Top 10 Gainers:
- Universe Pharmaceuticals Inc (UPC:NASDAQ), 222.86%
- MSP Recovery Inc. (LIFW:NASDAQ), 103.77%
- Gaxos.ai Inc Com (New) (GXAI:NASDAQ), 83.1%
- SharpLink Gaming Ltd. (SBET:NASDAQ), 79.39%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 64.76%
- ADC Therapeutics SA (ADCT:NYSE), 63.02%
- Avalon GloboCare Corp. (ALBT:NASDAQ), 54.89%
- Asana Inc. Class A (ASAN:NYSE), 43.53%
- Prestige Wealth Inc. (PWM:NASDAQ), 41.28%
- United States Antimony Corporation (UAMY:NYSEMKT), 40.74%